Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem vs Ceftriaxone in Complicated Urinary Tract Infections
NCT01014013Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ertapenem in complicated urinary tract infection (cUTI), sponsored by Merck & Co.. Started Apr 2008; status: completed.
02
Drugs
ertapenem
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT01014013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014013.